Scientists at the Danish Institute of Agricultural Sciences say they have successfully impregnated a pig with cloned embryos.
The cloned animals, expected to be born in Denmark in June, will provide valuable insights into human disease, lead scientist Gabor Vajta told MIDT-VEST.
The piglets will be used to study Alzheimer's disease, Parkinson's disease and other genetic diseases, reported the Copenhagen Post Friday.
Denmark's Parliament changed legislation last year to permit cloning of animals for research purposes only.
Copyright 2006 by United Press International
Related stories:
Scientists try to clone Alzheimer's pig
A team of Tjele, Denmark, scientists is trying to clone pigs that are suffering from Alzheimer's disease.
Researchers identify virus behind mysterious parrot disease
Researchers at the University of California, San Francisco, have identified a virus behind the mysterious infectious disease that has been killing parrots and exotic birds for more than 30 years.
Same drug, different results: MUHC researcher on the path to personalized medicine
Minor genetic differences between individuals change the effect of a common medication, study shows
Medicine has moved a little bit closer to the era of tailor-made treatments, based on the unique genetic profiles of individual patients, according to recent research conducted by Dr Rima Rozen of the Research Institute of the McGill University Health Centre (RI MUHC) at the Montreal Children's Hospital and McGill University. Her study, published June 18 in the journal Pharmacogenetics and Genomics, shows how minor genetic differences between individuals alter the way a common drug affects the body.
Patient's own infection-fighting T cells put late-stage melanoma into long-term remission
Case is first to show safety and effectiveness of using cloned cells alone to kill tumors
Researchers describe the first successful use of a human patient's cloned infection-fighting T cells as the sole therapy to put an advanced solid-tumor cancer into long-term remission. A team led by Cassian Yee, M.D., an associate member of the Clinical Research Division at Fred Hutchinson Cancer Research Center, reports these findings in the June 19 issue of the
New England Journal of Medicine.
Researchers identify proteins that help develop mammalian hearts
The absence of two proteins in mammalian embryos prevents the development of a healthy heart, a new study by researchers at the Medical College of Wisconsin, Milwaukee, has found.
New lymphoma therapies targets diverse and difficult cancer
The fifth leading cause of cancer in the United States, lymphoma is made up of more than 40 rare and highly diverse diseases that target the body's lymphatic system. Lymphomas include both one of the fastest growing cancers -- Burkitt's lymphoma, which can double in size in as little as a day -- and one of the slowest, chronic lymphocytic leukemia (CLL).
Clues to ancestral origin of placenta emerge in Stanford study
Researchers at the Stanford University School of Medicine have uncovered the first clues about the ancient origins of a mother's intricate lifeline to her unborn baby, the placenta, which delivers oxygen and nutrients critical to the baby's health.
Blood vessel protein reverses macular degeneration, diabetic retinopathy in mice
Two major eye diseases and leading causes of blindness—age-related macular degeneration and diabetic retinopathy—can be reversed or even prevented by drugs that activate a protein found in blood vessel cells, researchers at the University of Utah School of Medicine and several other institutions have announced in a new study.